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Quantitative RT PCRPreanalytical handling of tissue samples can inﬂuence bioanalyte quality and ultimately outcome of analytical
results. The aim of this study was to compare RNA quality, performance in real time RT PCR and histology of
formalin-ﬁxed tissue to that of tissue ﬁxed and stabilized with a formalin-free ﬁxative, the PAXgene Tissue
System (PAXgene), in an animal model under highly controlled preanalytical conditions. Samples of rat
liver, kidney, spleen, intestine, lung, heart muscle, brain, and stomach tissue were either ﬁxed in formalin
or ﬁxed in PAXgene or fresh frozen in liquid nitrogen. RNA was extracted from all samples, examined for in-
tegrity in microcapillary electrophoresis, and used in a series of quantitative RT PCR assays with increasing
amplicon length. Histology of parafﬁn-embedded samples was determined by staining with hematoxylin
and eosin.
Histology of all formalin-ﬁxed and PAXgene ﬁxed samples was comparable. RNA with acceptable integrity
scores could be isolated from all embedded tissues, 4.0 to 7.2 for formalin and 6.4 to 7.7 for PAXgene, as com-
pared to 8.0 to 9.2 for fresh frozen samples. While RNA with acceptable RINs (RNA integrity number) could be
isolated from formalin-ﬁxed samples, in microcapillary electrophoresis this RNA separated with a slower mi-
gration rate and displayed diffuse, less focused peaks for ribosomal RNA as compared to RNA from frozen or
PAXgene ﬁxed samples. Furthermore, RNA from formalin-ﬁxed tissues exhibited inhibition in quantitative RT
PCR assays which increased with increasing amplicon length, while RNA from PAXgene ﬁxed samples did not
show such inhibition.
In conclusion, our results demonstrate that excluding other preanalytical factors, PAXgene Tissue System
preserves histology similarly to formalin, but unlike formalin, does not chemically modify RNA. RNA puriﬁed
from PAXgene ﬁxed tissues is of high integrity and performs as well as RNA from fresh frozen tissue in RT PCR
regardless of amplicon length.
© 2012 Elsevier Inc. Open access under CC BY-NC-ND license.Introduction
In recent years, new molecular methods have enabled testing for
global gene, protein, and protein pathway activation expression pro-
ﬁles and/or somatic mutations in cancer from individual patients.
These methods have enabled identiﬁcation of biomarkers which
better deﬁne prognosis, and treatment options and lead to the devel-
opment of new drugs which interfere with themolecular mechanisms
of malignancy in an individual patient. For this so called personalizedded.
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-ND license.medicine, it is often necessary to analyze biomarkers from a clinical
sample, most often a primary tumor or biopsy from a suspectedmalig-
nancy. Many preanalytical factors have an inﬂuence on the quality of
the biomarker to be analyzed and, ultimately, on the outcome of ana-
lytical results. These factors include both warm and cold ischemia
times, type of ﬁxative, ﬁxation time, tissue sample size, transport con-
ditions, tissue processing protocol, and, most important for biobanks,
sample storage conditions (Chung et al., 2008; Engel and Moore,
2011; Hatzis et al., 2011; Hewitt et al., 2008). The lack of access to
well characterized, highly preserved tissue samples was recognized
as a major bottleneck for identiﬁcation of new biomarkers and the
main reason so few ostensible biomarkers have been validated for
routine clinical use (Poste, 2011).
Formalin, a 4% aqueous formaldehyde solution, is the most widely
used ﬁxative for preservation of tissue morphology and examination
by histological or immunohistochemical techniques. Formalin has
189D. Groelz et al. / Experimental and Molecular Pathology 94 (2013) 188–194been used for this purpose with only a few minor changes since its
introduction in the late 19th century (Blum, 1894). Although itsmech-
anism of action is still not fully understood, formalin ﬁxes tissue by
chemical modiﬁcation of biomolecules, forming crosslinks between
proteins and nucleic acids (Masuda et al., 1999). Large archives
of formalin-ﬁxed, parafﬁn-embedded (FFPE) blocks of tissue exist
throughout the world, and huge efforts have been made to improve
nucleic acid puriﬁcation from these stored tissues in order to make
these archives accessible for discovery of new biomarkers. This effort
has been largely unsuccessful. Due to the harsh conditions necessary
to break the protein-nucleic acid crosslinks and reverse or partially
reduce chemicalmodiﬁcations, biomolecules isolated from FFPE tissue
are of limited use for molecular analysis (McSherry et al., 2007;
Tournier et al., 2012; von Smolinski et al., 2005; Williams et al.,
1999). Snap-freezing of tissues in liquid nitrogen and storage at low
temperatures, widely accepted to be the best way to preserve proteins
and nucleic acids in tissues, can be inappropriate for a clinical environ-
ment because of intracellular ice formation and consequent morpho-
logical changes in the tissue (Desciak and Maloney, 2000), and
restrictions on the use of liquid nitrogen in clinics.
In the last few years, a number of ﬁxatives have been proposed as
alternatives to formalin (Delfour et al., 2006; Gillespie et al., 2002;
Mueller et al., 2011; Olert et al., 2001; Stanta et al., 2006; Vincek et
al., 2003), but none of these reagents has gained broader acceptance.
Recently, a new tissue ﬁxation method, the PAXgene® Tissue System
(PAXgene) was developed by PreAnalytiX GmbH (Hombrechtikon,
Switzerland). The two-reagent system consists of non-crosslinking
ﬁxative (PAXgene® Tissue Fix) and stabilizer (Paxgene® Tissue Stabi-
lizer) and is being evaluated as a part of the EU FP7 Project SPIDIA
(Standardization and improvement of generic preanalytical tools
and procedures for in vitro diagnostics), a consortium of European
universities and biotechnology companies. The aim of the SPIDIA con-
sortium is to standardize and improve generic preanalytical tools and
procedures for in vitro molecular diagnostics. Studies conducted by
SPIDIA consortium members have demonstrated that tissue samples
ﬁxed and stabilized with PAXgene can be used with conventional his-
tological stains such as hematoxylin and eosin (H&E) or immunohis-
tochemical staining (Kap et al., 2011). Other SPIDIA studies have
shown that PAXgene preserves proteins (Ergin et al., 2010), RNA,
miRNA and DNA (Viertler et al., 2012) in clinical samples.
Since many preanalytical variables extant in clinical settings are
known to have a profound inﬂuence on the quality and analytical
results of tissue biomolecules, we used an animal model (Rattus
norvegicus) and tightly controlled specimen collection and handling
conditions to minimize preanalytical variables and directly compare
histology and RNA in PAXgene ﬁxed tissue to that of formalin-ﬁxed
tissues. For our studies, warm and cold ischemia times, ﬁxative quality,
ﬁxation time, tissue processing andRNAextraction protocolswere stan-
dardized and optimized to yield optimal histological results as well as
the highest possible quality RNA from all ﬁxed samples. RNA from
fresh frozen tissues was always used as control RNA representing the
highest quality. As a corollary to our investigation of the effects of ﬁxa-
tives on RNA quality, we also investigated the effects of tissue process-
ing and embedding in parafﬁn on RNA from formalin or PAXgene
ﬁxed tissues.
Materials and methods
Tissue collection and preservation
Liver, kidney, spleen, intestine, lung, stomach, heart muscle and
brain were obtained from R. norvegicus. Rats were maintained and
sacriﬁced at the Universitätsklinikum Düsseldorf Tierversuchsanlage
(Düsseldorf, Germany) in accordance with the German protection of
animals act. Rats were raised to a weight of approximately 500 g
after which time the animals were sacriﬁced and organs removedwithin 10 min of sacriﬁce. Three adjacent, equally sized samples no
larger than 15 x 15×4 mmwere grossed from each organ. One sample
was fresh frozen (FF) immediately in liquid nitrogen, transported on
dry ice, and stored at −80 °C. For tissue ﬁxation, the remaining two
samples were placed into standard tissue cassettes (Simport Plastic
Ltd., Beloeil, Canada) and completely submerged in a container ﬁlled
with either 4% neutral buffered formaldehyde (NBF) (Sigma-Aldrich,
Steinheim, Germany) or PAXgene Tissue Fix (PreAnalytiX GmbH,
Hombrechtikon, CH) with ﬁxation solutions in a ratio of at least 20
parts ﬁxative to one part of tissue (v/v). Fixation was performed at
room temperature with formalin for 24 h or with the PAXgene Tissue
Fix for 4 h followed by a transfer into the PAXgene Tissue Stabilizer
(PreAnalytiX Gmbh, Hombrechtikon, CH) and stored for 72 h, to simu-
late transport or storage times in clinical settings. Effects of reversing
the recommended PAXgene protocol were investigated by incubating
tissue samples in the PAXgene Tissue Stabilizer reagent for 4 h before
ﬁxation with PAXgene Tissue Fix for 72 h. To investigate the effects of
tissue processing and parafﬁn embedding on the quality of RNA, RNA
from duplicate paired organ samples (two samples from each organ)
were either extracted immediately after ﬁxation in formalin or ﬁxation
and stabilization in PAXgene or after ﬁxation, stabilization processing,
and embedding in parafﬁn as described below.
Tissue processing
Samples ﬁxedwith formalin or PAXgenewere processed in separate
runs on an automated tissue processor (TP1020, Leica-microsystems,
Wetzlar, Germany). Afterﬁxation, formalin-ﬁxed sampleswerewashed
brieﬂy with deionized water and transferred to 70% ethanol. PAXgene
ﬁxed samples were directly transferred into 70% ethanol. Samples
remained in 70% ethanol for up to 8 h prior to initiation of processing.
The processing protocol for all samples, regardless of ﬁxation method
was as follows: incubation at 80%, 90%, 99% ethanol (2×), followed by
isopropanol (2×), xylene (2×) for no longer than 1 h at each position.
Tissue processing reagents were replaced after ﬁve runs to avoid re-
agent dilution and incomplete dehydration of the tissue samples. Ex-
treme care was taken to prevent the exposure to even trace amounts
of formalin of tissue ﬁxed and stabilized in PAXgene during the tissue
processing step by using separate batches of reagents for PAXgene and
formalin-ﬁxed tissues.
In order to prevent RNAdegradation due to extreme temperatures, a
low-melting point parafﬁn (Surgipath Paraplast-XTRA, Carl RothGmbH,
Karlsruhe, Germany) was used for inﬁltration and embedding of
samples regardless of method of ﬁxation. For inﬁltration of tissue with
parafﬁn, samples were incubated (3×1 h) under vacuum at 56 °C.
Within 30 min after inﬁltration, samples were, embedded. All blocks
of parafﬁn-embedded tissue were kept dry at 4 °C until use, and RNA
was isolated from the parafﬁn blocks within eight weeks from freshly
cut sections only.
Hematoxylin and eosin (H&E) staining
Sections of 4 μm thickness from FFPE and PAXgene ﬁxed,
parafﬁn-embedded (PFPE) tissue blocks were cut on a microtome
(RM2245, Leica-microsystems, Wetzlar, Germany) and stretched on a
water bath ﬁlled with fresh, deionized water heated to 40 °C for PFPE
and to 45 °C for FFPE tissue. Parafﬁn sections were removed from the
water bath within 1 min and placed on slides which were air-dried
overnight at room temperature. Staining was performed manually in
staining dishes starting with a de-waxing step in xylene, then rehydra-
tion with successive incubations in 96%, 80%, 70%, 60% ethanol, and
ﬁnally tap water. Hematoxylin (Merck KGaA, Darmstadt, Germany)
was applied for 1 min followed by a 3 min wash with tap water then
followed by staining for 3 min with eosin Y (Merck KGaA). After wash-
ing with tap water and dehydration with successive washes of 80%,
96%, 100% ethanol, and xylene, slides were mounted with Entellan
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examination.
RNA preparation
Total RNA was puriﬁed from 10 mg of fresh frozen (FF), formalin or
PAXgene ﬁxed tissue or from three sections, each 10 μm thick of FFPE
and PFPE tissue. For RNA isolation, the miRNeasy Mini kit (QIAGEN
GmbH, Hilden, Germany) was used for FF tissue, the miRNeasy FFPE
kit (QIAGEN) for formalin-ﬁxed and FFPE tissue, and the PAXgene Tis-
sue miRNA kit (PreAnalytiX GmbH) for PAXgene ﬁxed and PFPE tissue.
All preparations were done in triplicate with tissue samples from two
different animals for each ﬁxationmethod (FF, formalin-ﬁxed, PAXgene
ﬁxed, PFPE and FFPE). RNA yield was determined by spectrophotomet-
ric absorbance (Nanodrop ND-1000 spectrophotometer, Nanodrop
Technologies, Wilmington, USA) at 260 nm (A260). RNA integrity
was assessed by microcapillary electrophoresis on an Agilent 2100
Bioanalyzer and analyzed with the Agilent 2100 expert software
(Agilent Technologies, Waldbronn, Germany) to give RNA integrity
scores (RINs).
PCR ampliﬁcations
Using one forward primer and ten different reverse primers
(Table 1), PCR primers speciﬁc to the rat beta-actin gene (NC_005111)
were used to design individual quantitative, real-time RT PCR assays
which ampliﬁed ten different transcript sequences with lengths of
between 109 and 610 nucleotides (nt). One-step, RT PCR assays were
performed with 10 ng of total RNA on a Rotor-Gene Q (QIAGEN)
using theRotor-Gene SYBRGreen RT PCRKit (QIAGEN). Thermal cycling
conditions started with reverse transcription for 30 min at 60 °C
followed by an activation step of 15 min at 95 °C and 40 cycles of 15 s
at 94 °C, 30 s at 60 °C and 30 s at 70 °C. PCR reactions were run in
duplicate for each of the triplicate RNA extractions of tissue samples
from two different animals, resulting in 12 single reactions per assay
for each sample type (FF, PFPE or FFPE), 360 reactions per tissue type
or 2,880 PCR reactions in total. The acceptance criteria for single reac-
tions were that the cycle threshold (CT) of the reaction must be b40
and the difference in CT between duplicate reactions must be ≤2. The
validity of each individual PCR reaction was conﬁrmed by melting
point analysis. Melting curves had to be free of extraneous peaks or
peaks which indicated non-speciﬁc ampliﬁcation to be accepted as
valid. All data not meeting these acceptance criteria were excluded
from data analysis.
Results
Eight different rat tissue types, including liver, kidney, spleen,
intestine, lung, stomach, heartmuscle and brainwere used in a compar-
ison of morphology and RNA preservation in tissue samples ﬁxed either
with formalin or PAXgene. For optimal preservation of morphology and
RNA, all preanalytical steps of tissue procurement, ﬁxation, andTable 1
Oligonucleotide primer sequences for RT PCR.
PCR primer Primer sequence (5′→3′) Size (nt)
Rn_ACTB rev109 ACGCTCGGTCAGGATCTTCATG 109
Rn_ACTB rev158 TAATGTCACGCACGATTTCCC 158
Rn_ACTB rev189 AAGTCTAGGGCAACATAGCAC 189
Rn_ACTB rev236 TCTTCTCCAGGGAGGAAGAGGATG 236
Rn_ACTB rev287 GGAACCGCTCATTGCCGATAG 287
Rn_ACTB rev331 TTCCATACCCAGGAAGGAAGG 331
Rn_ACTB rev438 TACATGGTGGTGCCACCAGAC 438
Rn_ACTB rev465 TTCTGCATCCTGTCAGCAATG 465
Rn_ACTB rev569 ACAGTGAGGCCAGGATAGAG 569
Rn_ACTB rev610 TACTCCTGCTTGCTGATCCAC 610processing were performed according to recommendation of Hewitt
et al. (2008). RNA was puriﬁed from formalin-ﬁxed or PAXgene ﬁxed
tissue samples, before and after embedding into parafﬁn using the
QIAGEN miRNeasy FFPE Kit and the PAXgene Tissue miRNA Kit respec-
tively. As a reference for RNA quality and performance in RT PCR, repli-
cate samples from each tissue type were also fresh frozen in liquid
nitrogen and stored at -80 °C prior to RNA isolation.
Tissue histology
Fig. 1 depicts H&E stained tissue sections from all tissue types
obtained for this study. As can be seen in Fig. 1, both PAXgene and for-
malin ﬁxation gave generally comparable results thatwere adequate for
histologic identiﬁcation and structural status for multiple tissues. There
were differences, however, in that there was more cytoplasmic eosino-
philia evident in PAXgene ﬁxed tissues than in formalin-ﬁxed tissues.
This characteristic was especially evident in liver, heart, and brain
(Fig. 1a,m,o), but the increased eosinophilic staining seen in PAXgene
ﬁxed tissue seemed to enhance cytoplasmic detail as compared to
formalin-ﬁxed tissue. Nuclear features were good in both PAXgene
ﬁxed and formalin-ﬁxed tissues although somewhatmore intense in tis-
sues treatedwith PAXgene. Red cell lysis appeared to be characteristic of
PAXgeneﬁxationwhich tends to limit the depiction of capillaries (Fig. 1c,
d kidney) and the assessment of vascular congestion (Fig. 1e,f spleen) as
compared to formalin-ﬁxed tissues. Lung structure in formalin-ﬁxed
tissue is likewise easier to discern than in PAXgene ﬁxed tissues be-
cause the capillaries retain red cells (Fig. 1i,j); however, the distinc-
tion between the basophilic parietal and eosinophilic chief cells in
stomach tissue (Fig. 1k,l) is better in PAXgene than in formalin-ﬁxed
tissue.
The recommended procedure for ﬁxing and stabilizing tissue with
the PAXgene Tissue System isﬁrst to immerse the tissue in the PAXgene
Tissue Fix for a minimum of 2 h followed by immersion in the PAXgene
Tissue Stabilizer. The reagents are currently presented to the user in a
two-chambered container with the chambers clearly marked. While
reversing the recommended procedure (immersion in PAXgene Tissue
Stabilizer followed by transfer to the PAXgene Tissue Fix) is a re-
mote, but nevertheless possible mistake, we investigated whether
this improper use of the system affected histology of the mishandled tis-
sue. We found that immersion of tissue into PAXgene Tissue Stabilizer
before ﬁxation followed by the correct protocol could easily be detected
histologically by the appearance of a characteristic eosinophilic blurred
tissue border (Fig. 2). The broadness of the border depended on the
time the sample remained in the stabilizer before ﬁxation. After 4 h in
the stabilization reagent and 72 h in the ﬁxative (the reverse of the
recommended procedure) this zone measured between 0.25 and
0.33 mm. Tissues placed in stabilizer ﬁrst for shorter periods displayed
narrower eosinophilic borders. The border was more prominent in cer-
tain tissues like liver and kidney compared to lung (data not shown).
For all tissues for which the recommended procedure was followed,
the resultingmorphology as revealed byH&E stainingwas histologically
comparable to tissue ﬁxed with formalin.
RNA quality
In our study, RNA with moderately high or adequate RINs could be
isolated from all samples (Table 2) regardless of the method used to
preserve the tissue. RNA with the highest RIN scores (>8.0) was iso-
lated from FF tissue. RINs for RNA from formalin-ﬁxed tissue as well
as for RNA from PAXgene ﬁxed tissue were predominantly in the
range of 7 to 9, nearly as high as those from FF tissue even with an ad-
ditional 72 h room temperature storage time after the initial 4 h ﬁx-
ation period in the case of the PAXgene ﬁxed tissue samples. Tissue
processing and embedding in parafﬁn using our methods had only a
slight negative effect on RINs for PAXgene ﬁxed tissue samples with
an average decrease from 7.9 to 7.1. This decrease in RINs was higher
Fig. 1.Morphology of H&E stained rat liver (a, b), kidney (c, d), spleen (e, f), small intestine (g, h), lung (i, j), stomach (k, l), heart (m, n) and brain (o, p) tissue, from PAXgene ﬁxed
and stabilized, parafﬁn-embedded (PFPE: a, c, e, g, i, k, m, o) or formalin-ﬁxed, parafﬁn-embedded (FFPE: b, d, f, h, j, l, n, p) samples; original magniﬁcations for spleen, stomach and
brain ×200, liver, kidney, small intestine, lung and heart ×400.
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to 5.3. In addition the RIN scores of RNA extracted from FFPE tissue,
showed greater variability depending on tissue type. For liver and
kidney tissues, RIN scores, consistently higher than 6 were obtained,
and for liver, RIN scores as high as 8 could be achieved. For other tis-
sue types e.g. brain or heart muscle, RIN scores were in the range of 3
to 6.Despite adequate or even high RIN scores for RNA from formalin-
ﬁxed tissue, consistent differences in the actual electropherograms
between RNA from FFPE and PFPE or FF tissues could be observed.
As depicted in Fig. 3, the electropherogram of RNA from formalin-
ﬁxed tissues showed that this RNA separated at a slower migration
rate as compared to RNA from PFPE or FF tissue, resulting in 18S
and 28S rRNA peaks which were slightly shifted toward higher
Fig. 2.Morphology of PAXgene ﬁxed, H&E stained rat liver. (a) Recommended procedure
with ﬁxation stopped after 4 h by transfer into PAXgene Tissue Stabilizer and (b) improp-
er use with reversed procedure, e.g. 4 h in PAXgene Tissue Stabilizer and transfer into
PAXgene Tissue Fix reagent resulting in an eosinophilic blurred border (arrow); original
magniﬁcation ×100.
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appeared more diffuse and less focused when compared to the 18S
and 28S peaks of ribosomal RNA from FF and PFPE samples. These dif-
ferences, however, were not reﬂected in the RIN scores as calculated
by the Agilent 2100 expert software.
RNA performance in RT PCR
While RIN scores for all samples would indicate adequate to good
quality RNA had been extracted from tissue samples regardless of
preservation method, discrepancies in performance in RT PCR were
observed for RNA from different sources. Again, although RIN scores
for RNA from FFPE and PFPE tissues were, in some tissue types, com-
parable, real time RT PCR assays revealed RT PCR inhibition of RNA from
all FFPE tissues. Furthermore, inhibition increased with increasing
amplicon length (Fig. 4). Using the same amount of RNA for each
assay, the assay with the shortest amplicon (109 nt) demonstrated
the lowest difference in CT values between RNA from FF and FFPE tissue
samples withΔCT values (ΔCT=CT[FFPE]−CT[FF]) of 3 to 5, depending on
the tissue type. These differences increased linearly to 14 in the case of
the assay with the largest amplicon (610 nt). In contrast, using the
same amount of RNA from PFPE and FF tissue samples for RT PCR, the
ΔCT values (ΔCT=CT[PFPE]−CT[FF]) were consistently in the range of
−1 to 2 for all tissue types and did not vary with amplicon length.
Discussion
Preanalytical variables such as ischemia time, sample size, volume
and type of ﬁxative, ﬁxation time, and processing conditions can have
a profound inﬂuence on the quality of tissue and biomolecule preser-
vation (Chung et al., 2008; Hewitt et al., 2008; Verderio, 2012). Most
studies involving RNA from clinical, formalin-ﬁxed samples report
extensive RNA degradation with typical fragment sizes of 100 to 200 ntTable 2
Average RNA integrity values from ﬁxed rat tissue, 6 replicates each.
Fresh frozen PAXgene Formalin PFPE FFPE
Liver 9.0±0.4 7.9±0.2 7.8±0.2 7.2±0.3 7.2±0.7
Kidney 8.0±0.1 7.0±0.1 7.6±0.6 6.4±0.1 6.4±0.8
Spleen 8.6±0.9 8.5±0.5 8.2±0.7 7.5±0.3 5.5±1.1
Intestine 8.3±0.4 8.7±0.3 8.0±0.8 7.7±0.2 4.6±0.5
Lung 9.2±0.6 8.5±0.2 7.9±0.7 6.9±0.3 4.9±2.7
Heart 9.1±0.3 8.0±0.3 6.0±1.5 7.1±0.6 4.0±0.8
Brain 9.1±0.3 7.2±0.3 6.8±1.0 7.2±0.3 4.1±1.7
Stomach 8.4±0.5 7.4±0.3 7.2±1.5 7.0±0.1 5.7±1.6
Overall 8.7±0.6 7.9±0.7 7.4±1.1 7.1±0.5 5.3±1.7(Arzt et al., 2011; Chung et al., 2006; von Ahlfen et al., 2007). Because
our study focused speciﬁcally on the quality of RNA extracted from tis-
sues ﬁxed in either formalin or in a non-crosslinking ﬁxative system,
we chose to use an animal model in which sample handling, ﬁxation,
processing conditions and RNA puriﬁcation were tightly controlled and
favored the preservation of RNA. Our goal was to compare RNA quality
and performance in RT PCR assays between RNA extracted from
formalin-ﬁxed tissues and tissues ﬁxed with the PAXgene Tissue System
with all other preanalytical factors equal and favorable to recovery of in-
tact RNA.
Using this animal model, it was possible to minimize pre- and
post-excision times and standardize sample size, ﬁxative quality, ﬁx-
ation times, and tissue processing reagents and conditions. PAXgene
ﬁxed tissue was subjected to an additional three days of storage in
the stabilizer at room temperature to simulate conditions found in
clinical settings. We compared the morphology of PFPE tissue to that
of FFPE tissue using H&E staining as a common staining method. We
were also able to investigate the inﬂuence of the new PAXgene Tissue
ﬁxation method as well as the effect of processing conditions on RNA
quality by isolating RNA after ﬁxation/stabilization and after ﬁxation/
stabilization and processing including parafﬁn embedding. RNA from
fresh frozen replicate samples obtained immediately after excision
was always used as reference for RNA of the highest possible quality.
While there were some differences in staining intensities between
PFPE and FFPE tissues PAXgene Tissue was essentially comparable to
formalin-ﬁxed tissue for histology, except that red blood cells are
lysed in PAXgene ﬁxed tissue. Overall, the differences in histologic
features between PFPE and FFPE tissues do not appear to be diagnos-
tically signiﬁcant.
RIN scores obtained from microcapillary electrophoresis are very
often used to indicate overall RNA quality. The RIN is an algorithm
for assigning integrity values to puriﬁed RNA and is largely based on
the run times and peak heights of 18S and 28S ribosomal RNA which
are widely accepted as markers for total RNA, including transcript
RNA, quality (Schroeder et al., 2006). The algorithm assigns a 1 to 10
RIN score where level 10 RNA is completely intact. RIN scores of b10
but >5 indicate various levels of partial RNA degradation while RIN
scores of b5 indicate higher levels of degradation such that RNA with
RIN scores b3 are generally considered to be of very poor quality.
Whether or not this poor quality RNA is useful for gene expression anal-
ysis depends in large part on the size of the (degraded) transcript to be
ampliﬁed, and RT PCR assays are often designed to amplify short tran-
script sequences to accommodate RNA of poor quality (Antonov et al.,
2005). This approach, unfortunately limits the amount and quality of
gene expression data researchers can obtain from degraded tissue
samples.
In our study, the average RIN scores for six replicates of eight
different rat tissues from fresh frozen samples was high at 8.7
(Table 2). Theﬁxation process itself, whether by formalin or byPAXgene,
with all other preanalytical conditions kept under tight control, slightly
affected the RNA integrity as measured by RIN scores. Average RIN
scores of unprocessed formalin-ﬁxed and PAXgene ﬁxed tissues de-
creased to 7.4 and 7.9 respectively. The tissue processing protocol did
not greatly affect RIN scores from PAXgene ﬁxed tissue with a decrease
on average from 7.9 to 7.1. For formalin-ﬁxed tissue, this decrease due
to tissue processing was greater with the average RIN score dropping
from7.4 to 5.3. Therefore, FFPE and PFPE samples showed an average de-
crease in RIN scores of 2.1 and 0.8 respectively when compared to
paired, unprocessed samples. This indicates that in our model system,
processing, which included embedding in low melting point parafﬁn,
had only a minor effect on RNA integrity in PAXgene ﬁxed tissue but a
moderate effect on RNA integrity in formalin-ﬁxed tissue.
Insofar as the quality of RNA extracted from ﬁxed tissue is
concerned, an often neglected factor in obtaining high quality RNA
from tissue is the method used for RNA extraction. In recent studies
of non-crosslinking ﬁxatives, some investigators were only able to
Fig. 3. Analysis of total RNA isolated from rat liver fresh frozen (FF), PAXgene ﬁxed and stabilized parafﬁn-embedded (PFPE) or formalin-ﬁxed, parafﬁn-embedded (FFPE) by
microcapillary electrophoresis. Slower migration rate of RNA from FFPE is visible in (a) the electropherogram and (b) on the gel.
193D. Groelz et al. / Experimental and Molecular Pathology 94 (2013) 188–194extract RNA with RIN scores in the range of 1.8 to 2.5 from surgically
obtained specimens (Arzt et al., 2011; Moelans et al., 2011) While
some might conclude that these ﬁndings point to the lack of an
advantage in preserving RNA for non-crosslinking ﬁxatives, low RIN
scores can be partially explained by longer ischemia times, varied
preanalytical conditions seen in surgical pathology settings, or the
RNA extraction methods employed. To explain the last of these
three possibilities, it is well known that commercially available kits
for RNA extraction from FFPE tissue include optimized proteinase K
digestion steps often followed by heating steps in order to break the
methylene bridges that form crosslinks in formalin-ﬁxed tissue
(Masuda et al., 1999). Under these conditions, RNA is released from
a network of crosslinked proteins and nucleic acids. These methods,
however, should be applied only when necessary, i.e. when crosslinks
found in formalin-ﬁxed tissue must be removed from extracted RNA,
an unnecessary step in non-crosslinked tissue. This was illustrated by
the fact that in our study, RNA extracted from PFPE samples using kits
for RNA extraction from FFPE (miRNeasy FFPE kit, QIAGEN GmbH),
RIN scores of the resulting RNA were reduced by ≥3.0 as compared to
the RNA extracted with the PAXgene Tissue miRNA kit (data not
shown). This ﬁnding is due directly to the less harsh conditions
employed in the PAXgene Tissue miRNA kit. These RNA-friendly condi-
tions include the elimination of the 80 °C heating step after proteinase K
digestion.Fig. 4. Reverse transcription and ampliﬁcation using 10 ng RNA each from rat tissu
parafﬁn-embedded (FFPE), in ten different SYBR-Green real time one step RT PCR assays. A
delta-CT values (ΔCT=CT[FFPE]−CT[FF] or ΔCT=CT[PFPE]−CT[FF]) are shown for triplicate extr
and ﬁxation method.Nevertheless, in our study although we were able to isolate high
molecular weight RNA with relatively high RIN scores from FFPE tis-
sue, electropherograms of this RNA showed a shift of the ribosomal
RNA bands toward higher molecular weights, and the bands were
broader and less focused. This most likely indicates the presence of
chemical modiﬁcations of the RNA such as covalently linked residual
amino acids. This is consistent with the ﬁnding that, even with a com-
bination of optimized digestion and heating steps, it is not possible to
completely remove all chemical modiﬁcations from nucleic acids in
formalin-ﬁxed tissue (Masuda et al., 1999). When RNA is highly
degraded, as this is often the case in surgical samplesﬁxedwith formalin,
such modiﬁcations are no longer detectable because 18S and 28S RNA
peaks are no longer visible in the electropherogram. Since our methods
yielded FFPE tissue RNA with RIN scores as high as 8.0 (liver), it would
seem that the algorithm for the calculation of RIN score does not reﬂect
slight changes in molecular weight due to chemical modiﬁcation of the
RNA.
The results in RT PCR also indicate that the RNA from FFPE samples
most likely contained residual methyl groups, amino acids or other
chemical modiﬁcations which led to a premature stop of the reverse
transcription step. Furthermore, our results showed that, for formalin-
ﬁxed tissue RNA, the longer the transcript length, the greater the likeli-
hood for the premature stop of reverse transcription. Unlike RNA from
formalin-ﬁxed tissue, the RNA from PAXgene ﬁxed samples appearede fresh frozen (FF), PAXgene ﬁxed parafﬁn-embedded (PFPE) or formalin-ﬁxed,
mplicons of the rat beta-actin gene ranged from 109 to 610 nucleotide (nt). Average
actions from two different tissue samples ampliﬁed in duplicates for each type of tissue
194 D. Groelz et al. / Experimental and Molecular Pathology 94 (2013) 188–194not to be burdened with chemical modiﬁcations as revealed both by
microcapillary electrophoresis and RT PCR results. For RNA from PFPE
tissue, reverse transcription was not inhibited, and RNA puriﬁed from
PFPE samples performed similarly to RNA isolated from fresh frozen tis-
sue regardless of amplicon length. Since in our model system the RIN
scores obtained for RNA from FFPE and PFPE tissueswere in some tissue
types nearly equal, we conclude that RIN scores cannot be used as a pre-
dictor for performance in downstreamassays of RNA from formalin-ﬁxed
tissuewhile they do seem to indicate performance of RNA from PAXgene
ﬁxed tissue, the performance of which is comparable to RNA from fresh
frozen tissue. Based on these results, caution should be takenwhen com-
paring RNA from FFPE tissues to RNA from fresh frozen or PAXgene ﬁxed
samples RT PCR assays.
In conclusion, tissue ﬁxed with the PAXgene Tissue System is mor-
phologically comparable to formalin-ﬁxed tissue but yields RNA
which performs as well as RNA from fresh frozen tissue in RT PCR as-
says. While RNA with acceptable RIN scores could be isolated from
both FFPE and PFPE tissue, only RNA from PFPE tissue was comparable
to RNA from fresh frozen tissue in real time RT PCR assays and for all
ampliﬁcations of transcript sequences from 109 to 610 nt. For studies
involving prospective tissue collection for which the downstream anal-
ysis either requires RNA or is unspeciﬁed at the time of collection, the
PAXgene Tissue System might be useful, since histology of PAXgene
ﬁxed tissue is comparable to that of formalin-ﬁxed tissue, but the per-
formance of PAXgene Tissue RNA, unlike formalin-ﬁxed RNA, is identi-
cal to FF tissue RNA in RT PCR assays.
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